Top Markets
Coin of the day
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Clasificación en acciones #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Precio por acción
$25.61
Última sincronización: 2025-10-10
Capitalización bursátil
$1.37B
Cambio (1 día)
0.20%
Cambio (1 año)
1.59%
País
US
Comercio Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Categoría

Historial de rendimiento por dividendo de Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
Rendimiento por dividendo (TTM) de Harrow Health, Inc. 8.625% Senior Notes due 2026 (símbolo bursátil: HROWL) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras